Overview
Background
Dr James Wood's research focuses primarily on the design and synthesis of organic ligands to complex inorganic radioisotopes for radiopharmaceutical applications. His work spans across the design and synthesis of these ligands, through to radiolabelling of these compounds and assessing them within animal models. He is particularly interested in applications of these ligands that grant greater flexability or utility to diagnostic and therapeutic platforms.
James works within the ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals at the Centre for Advanced Imaging, working with industry partners to excelerate the production of novel radiopharmaceuticals.
Availability
- Dr James Wood is:
- Available for supervision
Fields of research
Qualifications
- Bachelor (Honours) of Science (Advanced), University of Sydney
- Doctor of Philosophy of Medicine, University of Sydney
Works
Search Professor James Wood’s works on UQ eSpace
2025
Conference Publication
Optimising VHH-based radiopharmaceuticals: addressing pharmacokinetics and renal clearance challenges
Huda, Pie, Owen, David, Bell, Craig, Wood, James, Humphries, James and Thurecht, Kristofer (2025). Optimising VHH-based radiopharmaceuticals: addressing pharmacokinetics and renal clearance challenges. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109460
2025
Conference Publication
Pre-targeting of PEG-based nanomedicines: precise delivery of potent payloads
Fletcher, Nicholas, Thurecht, Kristofer, Chu, Weijing, Huda, Pie, Humphries, James and Wood, James (2025). Pre-targeting of PEG-based nanomedicines: precise delivery of potent payloads. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109150
2025
Conference Publication
D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffold
Wood, James, Ghosh, Saikat, Houston, Zachary, Fletcher, Nicholas, Humphries, James, Mardon, Karine, Akhter, Dewan, Tieu, William, Ivashkevich, Alesia, Wheatcroft, Michael, Thurecht, Kristofer and Codd, Rachel (2025). D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffold. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109244
2025
Journal Article
An elastic siderophore synthetase and rubbery substrates assemble multimeric linear and macrocyclic hydroxamic acid metal chelators
Nolan, Kate P., Rosser, Callum A., Wood, James L., Font, Josep, Sresutharsan, Athavan, Wang, Joseph, Markham, Todd E., Ryan, Renae M. and Codd, Rachel (2025). An elastic siderophore synthetase and rubbery substrates assemble multimeric linear and macrocyclic hydroxamic acid metal chelators. Chemical Science, 16 (5), 2180-2190. doi: 10.1039/d4sc04888a
2024
Journal Article
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements
Wood, James Liam, Ghosh, Saikat, Houston, Zachary, Fletcher, Nicholas, Humphries, James, Mardon, Karine, Akhter, Dewan T., Tieu, William, Ivashkevich, Alesia, Wheatcroft, Michael P., Thurecht, Kristofer J. and Codd, Rachel (2024). A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements. Chemical Science, 15 (30), 11748-11760. doi: 10.1039/d4sc02851a
2023
Journal Article
Reduction-cleavable desferrioxamine B pulldown system enriches Ni(II)-superoxide dismutase from a Streptomyces proteome
Ni, Jenny, Wood, James L., White, Melanie, Lihi, Norbert, Markham, Todd E., Wang, Joseph, Chivers, Peter and Codd, Rachel (2023). Reduction-cleavable desferrioxamine B pulldown system enriches Ni(II)-superoxide dismutase from a Streptomyces proteome. RSC Chemical Biology, 4 (12), 1064-1072. doi: 10.1039/d3cb00097d
2022
Other Outputs
Ligands and their use
Codd, Rachel, Wood, James Liam and Brown, Christopher John McCormack (2022). Ligands and their use. WO2022133537.
Supervision
Availability
- Dr James Wood is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Development of novel nanoparticles for enhanced radiotherapeutic efficacy
Associate Advisor
Other advisors: Dr Nick Fletcher, Dr James Humphries, Professor Kristofer Thurecht
-
Doctor Philosophy
Molecular alpha radiotherapy using nanomaterials mediated via pre-targeting strategy
Associate Advisor
Other advisors: Dr Nick Fletcher, Professor Kristofer Thurecht
Media
Enquiries
For media enquiries about Dr James Wood's areas of expertise, story ideas and help finding experts, contact our Media team: